227 related articles for article (PubMed ID: 22547623)
1. Rifapentine is not more active than rifampin against chronic tuberculosis in guinea pigs.
Dutta NK; Illei PB; Peloquin CA; Pinn ML; Mdluli KE; Nuermberger EL; Grosset JH; Karakousis PC
Antimicrob Agents Chemother; 2012 Jul; 56(7):3726-31. PubMed ID: 22547623
[TBL] [Abstract][Full Text] [Related]
2. Potent rifamycin-sparing regimen cures guinea pig tuberculosis as rapidly as the standard regimen.
Dutta NK; Alsultan A; Gniadek TJ; Belchis DA; Pinn ML; Mdluli KE; Nuermberger EL; Peloquin CA; Karakousis PC
Antimicrob Agents Chemother; 2013 Aug; 57(8):3910-6. PubMed ID: 23733473
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the 'Denver regimen' against acute tuberculosis in the mouse and guinea pig.
Ahmad Z; Nuermberger EL; Tasneen R; Pinn ML; Williams KN; Peloquin CA; Grosset JH; Karakousis PC
J Antimicrob Chemother; 2010 Apr; 65(4):729-34. PubMed ID: 20123722
[TBL] [Abstract][Full Text] [Related]
4. Delamanid Kills Dormant Mycobacteria
Chen X; Hashizume H; Tomishige T; Nakamura I; Matsuba M; Fujiwara M; Kitamoto R; Hanaki E; Ohba Y; Matsumoto M
Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28373190
[TBL] [Abstract][Full Text] [Related]
5. Treatment of tuberculosis with rifamycin-containing regimens in immune-deficient mice.
Zhang M; Li SY; Rosenthal IM; Almeida DV; Ahmad Z; Converse PJ; Peloquin CA; Nuermberger EL; Grosset JH
Am J Respir Crit Care Med; 2011 May; 183(9):1254-61. PubMed ID: 21330452
[TBL] [Abstract][Full Text] [Related]
6. Short-course therapy with daily rifapentine in a murine model of latent tuberculosis infection.
Zhang T; Zhang M; Rosenthal IM; Grosset JH; Nuermberger EL
Am J Respir Crit Care Med; 2009 Dec; 180(11):1151-7. PubMed ID: 19729664
[TBL] [Abstract][Full Text] [Related]
7. Isoniazid or moxifloxacin in rifapentine-based regimens for experimental tuberculosis?
Rosenthal IM; Zhang M; Almeida D; Grosset JH; Nuermberger EL
Am J Respir Crit Care Med; 2008 Nov; 178(9):989-93. PubMed ID: 18723432
[TBL] [Abstract][Full Text] [Related]
8. Dose-ranging comparison of rifampin and rifapentine in two pathologically distinct murine models of tuberculosis.
Rosenthal IM; Tasneen R; Peloquin CA; Zhang M; Almeida D; Mdluli KE; Karakousis PC; Grosset JH; Nuermberger EL
Antimicrob Agents Chemother; 2012 Aug; 56(8):4331-40. PubMed ID: 22664964
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of tuberculosis chemotherapy correlates with resistance to Mycobacterium tuberculosis infection in animal models.
Ahmad Z; Fraig MM; Pinn ML; Tyagi S; Nuermberger EL; Grosset JH; Karakousis PC
J Antimicrob Chemother; 2011 Jul; 66(7):1560-6. PubMed ID: 21602551
[TBL] [Abstract][Full Text] [Related]
10. Daily dosing of rifapentine cures tuberculosis in three months or less in the murine model.
Rosenthal IM; Zhang M; Williams KN; Peloquin CA; Tyagi S; Vernon AA; Bishai WR; Chaisson RE; Grosset JH; Nuermberger EL
PLoS Med; 2007 Dec; 4(12):e344. PubMed ID: 18092886
[TBL] [Abstract][Full Text] [Related]
11. Acquired rifamycin monoresistance in patients with HIV-related tuberculosis treated with once-weekly rifapentine and isoniazid. Tuberculosis Trials Consortium.
Vernon A; Burman W; Benator D; Khan A; Bozeman L
Lancet; 1999 May; 353(9167):1843-7. PubMed ID: 10359410
[TBL] [Abstract][Full Text] [Related]
12. Activities of TMC207, rifampin, and pyrazinamide against Mycobacterium tuberculosis infection in guinea pigs.
Shang S; Shanley CA; Caraway ML; Orme EA; Henao-Tamayo M; Hascall-Dove L; Ackart D; Lenaerts AJ; Basaraba RJ; Orme IM; Ordway DJ
Antimicrob Agents Chemother; 2011 Jan; 55(1):124-31. PubMed ID: 20937788
[TBL] [Abstract][Full Text] [Related]
13. Weekly rifapentine/isoniazid or daily rifampin/pyrazinamide for latent tuberculosis in household contacts.
Schechter M; Zajdenverg R; Falco G; Barnes GL; Faulhaber JC; Coberly JS; Moore RD; Chaisson RE
Am J Respir Crit Care Med; 2006 Apr; 173(8):922-6. PubMed ID: 16474028
[TBL] [Abstract][Full Text] [Related]
14. Experimental ocular tuberculosis in guinea pigs.
Rao NA; Albini TA; Kumaradas M; Pinn ML; Fraig MM; Karakousis PC
Arch Ophthalmol; 2009 Sep; 127(9):1162-6. PubMed ID: 19752425
[TBL] [Abstract][Full Text] [Related]
15. Sterilizing activities of novel combinations lacking first- and second-line drugs in a murine model of tuberculosis.
Williams K; Minkowski A; Amoabeng O; Peloquin CA; Taylor D; Andries K; Wallis RS; Mdluli KE; Nuermberger EL
Antimicrob Agents Chemother; 2012 Jun; 56(6):3114-20. PubMed ID: 22470112
[TBL] [Abstract][Full Text] [Related]
16. Immunodeficiency and Intermittent Dosing Promote Acquired Rifamycin Monoresistance in Murine Tuberculosis.
Park SW; Tasneen R; Converse PJ; Nuermberger EL
Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28874368
[TBL] [Abstract][Full Text] [Related]
17. Comparative studies evaluating mouse models used for efficacy testing of experimental drugs against Mycobacterium tuberculosis.
De Groote MA; Gilliland JC; Wells CL; Brooks EJ; Woolhiser LK; Gruppo V; Peloquin CA; Orme IM; Lenaerts AJ
Antimicrob Agents Chemother; 2011 Mar; 55(3):1237-47. PubMed ID: 21135176
[TBL] [Abstract][Full Text] [Related]
18. A Phase 2 Randomized Trial of a Rifapentine plus Moxifloxacin-Based Regimen for Treatment of Pulmonary Tuberculosis.
Conde MB; Mello FC; Duarte RS; Cavalcante SC; Rolla V; Dalcolmo M; Loredo C; Durovni B; Armstrong DT; Efron A; Barnes GL; Marzinke MA; Savic RM; Dooley KE; Cohn S; Moulton LH; Chaisson RE; Dorman SE
PLoS One; 2016; 11(5):e0154778. PubMed ID: 27159505
[TBL] [Abstract][Full Text] [Related]
19. Bactericidal potencies of new regimens are not predictive of their sterilizing potencies in a murine model of tuberculosis.
Andries K; Gevers T; Lounis N
Antimicrob Agents Chemother; 2010 Nov; 54(11):4540-4. PubMed ID: 20713662
[TBL] [Abstract][Full Text] [Related]
20. Poly (DL-lactide-co-glycolide) nanoparticle-based inhalable sustained drug delivery system for experimental tuberculosis.
Pandey R; Sharma A; Zahoor A; Sharma S; Khuller GK; Prasad B
J Antimicrob Chemother; 2003 Dec; 52(6):981-6. PubMed ID: 14613962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
